Geneoscopy, Inc. develops and commercializes RNA-based diagnostic tests for colorectal cancer and inflammatory bowel disease.

Nucleus RadioPharma is a company that aims to modernize the clinical development, manufacturing, and supply chain of radiopharmaceuticals to ensure broader patient access and improve the movement and delivery of materials to patients.